No Data
Rena Science, Genie and others.
The complete acquisition and cancellation of the remaining 27th subscription rights of Shannon (with exercise price adjustment clause) and the issuance of the 23rd subscription rights (with exercise price adjustment clause) (number of potential Stocks 1.37 million 4,600 stocks, raised approximately 0.143 billion yen) issuance of the 24th subscription rights (with exercise price adjustment clause) (number of potential Stocks 6 million stocks, raised approximately 0.567 billion yen) acquisition of BASEE store's Stocks (4304) and making it a subsidiary, and the remaining 15th and 18th subscription rights of Kids Bio (4584).
Kidswell Bio: Confirmation letter
Kidswell Bio: Half Year Report - 25th Term (2024/04/01 - 2025/03/31)
Kidswell Bio: Supplementary explanation of financial results for the 2nd quarter of the fiscal year ending March 31, 2025
Kidswell Bio: Notice regarding consolidated earnings forecasts
Kidswell Bio: Summary of financial results for the 2nd quarter (interim period) for the fiscal year ending March 31, 2025 [Japanese GAAP] (consolidated)
No Data